接种COVID-19疫苗的个体的抗体标位:系统性审查

Aminoddin M Domado1, Homobono Jacob F Adaza, Andrea Pauline Nicole C Beltran

  • 1School of Medical Laboratory Science, Far Eastern University-Nicanor Reyes Medical Foundation, Quezon City, Philippines.

Journal of biosciences
|September 6, 2023
PubMed
概括

本综述比较了COVID-19疫苗类型和施用方法. 使者RNA (mRNA) 疫苗在作为同源增强剂使用时显示出更高的中和抗体 (NAb) 标位,从而提供更好的病毒保护.